CASP8 and breast carcinoma: Collectively, our findings complement previous epidemiological findings, associating CASP8 -652InsDel and CASP8 Asp302His with decreased breast cancer susceptibility4,5,24–26 and extend clinical relevance of the -652Del variant from predicting breast cancer susceptibility to prognostic stratification.